<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANS</journal-id>
<journal-title-group>
<journal-title>Annals of Neurosciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0972-7531</issn>
<issn pub-type="epub">0976-3260</issn>
<publisher>
<publisher-name>Indian Academy of Neurosciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">07140404</article-id>
<article-id pub-id-type="doi">10.5214/ans.0972.7531.2007.140404</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Melatonin and neurodegenration</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MELATONIN &#x2013; A &#x201C;MAGIC BIOMOLECULE&#x201D;</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jain</surname>
<given-names>Ayushi</given-names>
</name>
<xref ref-type="aff" rid="A1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhatnagar</surname>
<given-names>Maheep</given-names>
<prefix>Dr.</prefix>
</name>
<xref ref-type="aff" rid="A1"/>
<xref ref-type="corresp" rid="COR1">&#x0002a;</xref>
</contrib>
</contrib-group>
<aff id="A1"> <institution>Neuroscience laboratory, Department of Zoology, Univ College of Science, ML Sukhadia University Udaipur</institution><italic>, Rajasthan-313001,</italic> <country>India</country></aff>
<author-notes>
<corresp id="COR1"><label>&#x0002a;</label>
<named-content content-type="Corresponding Author"><bold>Dr. Maheep Bhatnagar</bold></named-content>
<institution>Professor of Zoology, University College of Science, M.L.Sukhadia University</institution><italic>, Udaipur, Rajasthan-313001,</italic> <country>India</country> <phone>Phone No. 0294&#x2013;2413955(O) 0294&#x2013;2441250 (R)</phone> <italic>E-mail address:</italic> <email>mbhatnagar@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2007</year>
</pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>108</fpage>
<lpage>114</lpage>
<permissions>
<copyright-statement>Copyright &#x00A9; 2007, Annals of Neurosciences</copyright-statement>
<copyright-year>2007</copyright-year>
</permissions>
<abstract abstract-type="Abstract">
<p>Melatonin is the pineal hormone and its activity is associated with the two known receptors-ML1 and ML2. Melatonin is an indoleamine and has found potent role in the biological regulation of circadian rhythms, sleep-mood disorders, cancer, neurodegenerative disorders and aging. Melatonin passively diffuses into bloodstream showing its maximum effectiveness. Melatonin preserves mitochondrial homeostasis, increases gene expression for antioxidant enzymes and enhances quality of life. It has proved to be a powerful antioxidant and its efficacy is particularly exhibited in neurodegenerative disorders like Alzheimer's, Parkinson's disease whose pathogenesis is associated with the cytotoxic effect of oxygen free radicals. Therapeutic trials with melatonin have been effective in slowing down the progression of some neurodegenerative disorders. Studies suggest that melatonin may have a clinical potential for the treatment of neurodegenerative disorders and many other incurable ailments.</p>
</abstract>
<kwd-group kwd-group-type="Key Words">
<kwd>Pineal</kwd>
<kwd>Melatonin</kwd>
<kwd>Antioxidant</kwd>
<kwd>Neurodegenerative disorders</kwd>
<kwd>Therapeutic trials</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="Introduction">
<title>Introduction</title>
<p>French philosopher and scientist Rene Descartes has declared in the seventeenth century that the pineal gland is "the seat of soul". Though first identified by Aron Lerner 'in 1958 and now the object of over 20,000 peer reviewed scientific studies, scientists are still discovering daily new and vital roles for this 'small but mighty indoleamine'. The pea-sized gland, pineal in the brain produces melatonin, a hormone secreted most profusely as the darkness falls and is the smallest, hormone secreted in humans, in terms of volume having powerful effects. Melatonin, a derivative of an essential amino acid tryptophan, was first identified in bovine pineal tissue and subsequently it has been portrayed exclusively as a hormone. It is released every night as part of our time dependent biorhythms to help induce sleep and recuperation from fatigue. This hormone is postulated to mediate photoperiodicity, is light sensitive and subject to oxidation. It is not only a powerful hormone, synthesized in the pineal gland, secreted into the cerebrospinal fluid and the circulation, influenced by the light and dark but it is also a ubiquitous nutrient food, being found in many common plants from bananas to morello cherries and in most of the cereals. Melatonin is an unusually controversial biomolecule. This neurologically and endocrinolo-gically active substance can reset the biological clock, fix jet lag, ward off depressive and panic disorders, fight common cold, cancers and even aging. Melatonin is potent antioxidant. It has also been described as the pacemaker of the aging clock in humans. It fortifies the immune system and stabilizes the nervous system. Melatonin plays an important role in proliferation of neuronal cell. It is recently called as a wonder drug useful for treating everything from AIDS to Alzheimer's. The reasons for this non-ending interest in melatonin is due to our modern age of jet travel, telecommunications, advanced techno times, electronic gadget-age and commercialization but it's darker counterpart as direct and indirect effects on the biotic life totally unknown.</p>
<p>What is the pineal gland?</p>
<fig position="float" id="F1"><label>Fig.1</label><caption><p>Longitudinal section of human brain to show the location of pineal gland.</p></caption><graphic xlink:href="http://www.annalsofneurosciences.org/images/14_4/ANS-14-108-g001.tif"/></fig>
<p>The pineal gland is a tiny and mighty gland, crucial to the healthy functioning of our physical, mental, emotional and spiritual body. Scientists consider pineal to be the master gland, "the regulator of the regulators" which ensures proper biorhythms of the hormonal and cellular systems (<xref ref-type="bibr" rid="R01"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R02"><sup>2</sup></xref>). The pineal gland or <italic>epiphysis</italic> synthesizes and secretes melatonin, a structurally simple hormone that communicates information about environmental lighting to various parts of the body, which induces sleep, regulates the circadian rhythms (<xref ref-type="bibr" rid="R03"><sup>3</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="R04"><sup>4</sup></xref>). Ultimately, melatonin has the ability to entrain biological rhythms and has important effects on reproductive function of many animals. The light-transducing ability of the pineal gland has led some to call the pineal the "third eye". As one grows older, balanced flow of the vital fluids is disturbed, the pineal gland starts to calcify or harden and the melatonin production decreases and too much of serotonin is released (<xref ref-type="bibr" rid="R05"><sup>5</sup></xref>).</p>
</sec>
<sec id="s2" sec-type="Anatomy of the Pineal Gland">
<title>Anatomy of the Pineal Gland</title>
<p>The pineal gland is a small organ shaped like a pine cone (hence its name). It is located on the midline, attached to the posterior end of the roof of the third ventricle in the brain. The pineal varies in size among species; in humans it is roughly 1 cm in length, whereas in dogs it is only about 1 mm long. To observe the pineal, reflect the cerebral hemispheres laterally and look for a small grayish bump in front of the cerebellum.</p>
<fig position="float" id="F2"><label>Fig. 2.</label><caption><p>The images show the pineal gland of a horse in relation to the brain.</p></caption><graphic xlink:href="http://www.annalsofneurosciences.org/images/14_4/ANS-14-109-g001.tif"/></fig>
<p>Histologically, the pineal is composed of "pinealocytes" and glial cells. In older animals, the pineal often contains calcium deposits-"brain sand" and the Melatonin concentration decrease, as one grows older (<xref ref-type="bibr" rid="R06"><sup>6</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="R08"><sup>8</sup></xref>).</p>
</sec>
<sec id="s3" sec-type="The retinal transmission of information about light-dark exposure to the pineal gland">
<title>The retinal transmission of information about light-dark exposure to the pineal gland</title>
<p>Synthesis and secretion of melatonin is dramatically affected by light exposure to the eyes. The fundamental pattern observed is that serum concentrations of melatonin are low during the daylight hours, and increase to a peak during the dark (<xref ref-type="bibr" rid="R09"><sup>9</sup></xref>). Light exposure to the retina is first relayed to the suprachiasmatic nucleus of the hypothalamus, (<xref ref-type="bibr" rid="R10"><sup>10</sup></xref>) an area of the brain well known to coordinate biological clock signals(<xref ref-type="bibr" rid="R01"><sup>1</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R11"><sup>11</sup></xref>). Fibers from the hypothalamus descend to the spinal cord and ultimately project to the superior cervical ganglia, from which post-ganglionic neurons ascend back to the pineal gland(<xref ref-type="bibr" rid="R12"><sup>12</sup></xref>). Thus, the pineal is similar to the adrenal medulla in the sense that it transduces signals from the sympathetic nervous system into a hormonal signal (<xref ref-type="bibr" rid="R13"><sup>13</sup></xref>).</p>
</sec>
<sec id="s4" sec-type="Melatonin: Synthesis, Secretion and Receptors">
<title>Melatonin: Synthesis, Secretion and Receptors</title>
<p>The pineal produces melatonin from serotonin. Serotonin is a neurotransmitter and is most highly concentrated in the pineal. The precursor to melatonin is serotonin, that itself is derived from the amino acid tryptophan. Within the pineal gland, serotonin is acetylated and then methylated to yield melatonin (<xref ref-type="bibr" rid="R14"><sup>14</sup></xref>). 6-sulphatoxy-melatonin (aMT6s) is the major metabolite of melatonin. Human body converts melatonin into aMT6s and excretes it in urine (<xref ref-type="bibr" rid="R15"><sup>15</sup></xref>). It is naturally synthesized from the amino acid tryptophan (derived from serotonin) by the enzyme 5-hyroxyindole-methyltransferases (<xref ref-type="bibr" rid="R16"><sup>16</sup></xref>). Circulating melatonin is mostly 6-hydroxylated molecule and excreted as 6-sulfatoxymelatonin. Pyrrole-ring cleavage is of higher importance in other tissues, especially the brain. The product, N1-acetyl-N2-formyl-5-methoxykynuramine, is formed by enzymatic, pseudoenzymatic, photocatalytic, and numerous free-radical reactions. Additional metabolites result from hydroxylation and nitrosation. The secondary metabolite, N1-acetyl-5-methoxykynuramine, supports mitochondrial function and down regulates cyclooxygenase2 levels (<xref ref-type="bibr" rid="R17"><sup>17</sup></xref>). The duration of melatonin secretion each day is directly proportional to the length of the night. Sufficiently bright light suppresses melatonin. Normally, production of melatonin is inhibited by light and permitted by darkness. Abnormal melatonin production is seen when rhythms are disordered;(<xref ref-type="bibr" rid="R18"><sup>18</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="R19"><sup>19</sup></xref>) for example as in shift work, jetlag, blindness, old age and poor sleep or some metabolic disorders. Two melatonin receptors have been identified from mammals designated Mel1A and Mel1B that are differentially expressed in different tissues (<xref ref-type="bibr" rid="R20"><sup>20</sup></xref>) and probably participate in implementing differing biologic effects. These are G protein-coupled cell surface receptors (<xref ref-type="bibr" rid="R21"><sup>21</sup></xref>). The highest density of receptors has been found in the suprachiasmatic nucleus of the hypothalamus, the anterior pituitary (predominantly pars tuberalis) and the retina (<xref ref-type="bibr" rid="R22"><sup>22</sup></xref>). Receptors are also found in several other areas of the brain (<xref ref-type="bibr" rid="R23"><sup>23</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="R24"><sup>24</sup></xref>). The membrane melatonin receptors also tontrols reproductive phenomenon in mammals (<xref ref-type="bibr" rid="R25"><sup>25</sup></xref>).</p>
<fig position="float" id="F3"><label>Fig.3</label><caption><p>Melatonin synthesis from serotonin in the pineal gland.</p></caption><graphic xlink:href="http://www.annalsofneurosciences.org/images/14_4/ANS-14-109-g002.tif"/></fig>
</sec>
<sec id="s5" sec-type="Melatonin chemistry">
<title>Melatonin chemistry</title>
<p>Empiric formula- C13 H16 N2 02</p>
<p>Molecular weight &#x2013; 232.28</p>
<p>Melting point-116.11c.</p>
<p>Bioavailability- 30 to 50 %</p>
<p>Elimination- 32 to 40 minutes (half life)</p>
<p>Metabolism-liver</p>
<p>Excretion-urine</p>
<p>Indicated for- jetlag, insomnia, sleeps disorders etc.</p>
</sec>
<sec id="s6" sec-type="Structure of melatonin">
<title>Structure of melatonin</title>
<p>5-methoxy-n acetyl tryptamine</p>
<fig position="float" id="UF1"><graphic xlink:href="http://www.annalsofneurosciences.org/images/14_4/ANS-14-109-g003.tif"/></fig>
<fig position="float" id="F4"><label>Fig. 4</label><caption><p>The histological section of pineal to show pinealocytes that secrete melatonin.</p></caption><graphic xlink:href="http://www.annalsofneurosciences.org/images/14_4/ANS-14-110-g001.tif"/></fig>
</sec>
<sec id="s7" sec-type="Occurrence">
<title>Occurrence</title>
<p>Melatonin is found in all living creatures from algae to humans, at levels that vary in a diurnal cycle. In animals melatonin is most highly concentrated in the brain (nervous tissue) produced by pinealocytes and also by retina (<xref ref-type="bibr" rid="R26"><sup>26</sup></xref>) and gastrointestinal tract. It distributes in all tissues and cellular compartments being especially high in the nucleus, mitochondria and bile (<xref ref-type="bibr" rid="R27"><sup>27</sup></xref>). Tissues producing melatonin are retina, human ovary, lens, human bone marrow (<xref ref-type="bibr" rid="R28"><sup>28</sup></xref>) etc. Melatonin, is produced by bacteria, protozoa, plants, fungi, invertebrates, and various extra pineal sites of vertebrates, including gut, skin, Harderian gland, and leukocytes (<xref ref-type="bibr" rid="R29"><sup>29</sup></xref>). In plants various plants from banana to Morella cherries and even in rice and all our cereal crops synthesize melatonin. Melatonin has been identified in a large number of plant taxa (<xref ref-type="bibr" rid="R30"><sup>30</sup></xref>). Among angiosperms, melatonin has been found in more than 30 species belonging to 19 different families and in both monocotyledons and dicotyledons (<xref ref-type="bibr" rid="R31"><sup>31</sup></xref>). Within plant tissues, melatonin has been found in roots, stems, leaves, fruit, and seeds. Most of the plants that have been analyzed are edible. (<xref ref-type="bibr" rid="R30"><sup>30</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R32"><sup>32</sup></xref>) Melatonin is present in the earliest life forms and is found in all organisms including bacteria, algae, fungi, plants, insects, and vertebrates including humans. As melatonin is also ingested in foodstuffs such as vegetables, fruits, rice, wheat and herbal medicines, from the nutritional point of view, melatonin can also be classified as a vitamin. It seems likely that melatonin initially evolved as an antioxidant, becoming a vitamin in the food chain, and in multicellular organisms (<xref ref-type="bibr" rid="R32"><sup>32</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R33"><sup>33</sup></xref>).</p>
</sec>
<sec id="s8" sec-type="Role and Effects">
<title>Role and Effects</title>
<p>When the sun goes down, darkness falls, the pineal goes to work. As melatonin production rises, one begins to feel less alert; body temperature starts to fall as well. Sleep seems more inviting. Then melatonin level drop quickly with dawning of a new day. Thus melatonin levels go hand in hand with light dark cycle. This hormone is the sleep trigger regulating the natural sleep cycle. It regulates the circadian rhythm that is the maintenance of biological clock of the brain at locus of suprachiasmatic nuclei (SCN) (<xref ref-type="bibr" rid="R34"><sup>34</sup></xref>). Melatonin plays a role of a marker of phases in the clock (<xref ref-type="bibr" rid="R16"><sup>16</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R35"><sup>35</sup></xref>).</p>
<p>One of the first experiments conducted to elucidate the function of the pineal, extracts of pineal glands from cattle were added to water containing tadpoles. Interestingly, the tadpoles responded by becoming very light in color or almost transparent due to alterations in melanin pigment distribution. Although such cutaneous effects of melatonin are seen in a variety of "lower species", the hormone does not have such effects in mammals or birds. It reverses the darkening effect on skin. It is light sensitive molecule and prone to self-oxidation. In hundreds of investigations melatonin has been documented as a direct free radical scavenger and an indirect antioxidant as well as an important immunomodulatory agent. Besides being a highly effective direct free radical scavenger and indirect antioxidant, (<xref ref-type="bibr" rid="R36"><sup>36</sup></xref>) melatonin has several features that make it of clinical interest (<xref ref-type="bibr" rid="R37"><sup>37</sup></xref>). Melatonin is readily absorbed when it is administered via any route, it crosses all morphophysiological barriers, e.g. cellular membranes, blood-brain barrier and placenta, with ease, it seems to enter all parts of every cell where it prevents oxidative damage, it preserves mitochondrial function, and it has low toxicity. While blood melatonin levels are normally low, tissue levels of the indoleamine can be considerably higher and at some sites, e.g., in bone marrow cells and bile, melatonin concentrations exceed those in the blood by several orders of magnitude. Actions are pleiotropic, immunostimulatory (<xref ref-type="bibr" rid="R38"><sup>38</sup></xref>) and cytoprotective mediated by membrane and nuclear receptors, other binding sites or chemical interactions (<xref ref-type="bibr" rid="R39"><sup>39</sup></xref>). Antioxidative protection, safeguarding of mitochondrial electron flux, (<xref ref-type="bibr" rid="R40"><sup>40</sup></xref>) and in particular, neuroprotection, have been demonstrated in many experimental systems (<xref ref-type="bibr" rid="R41"><sup>41</sup></xref>). Melatonin has antitumor activities as well. The elevated endogenous melatonin can exert oncostatic effect via immunomodulation or alteration of reproductive hormones or antioxidant activity. Elevated glucocorticoid hormone levels potently suppress adult hippocampal cell proliferation and in contrast melatonin increase cell proliferation, this implies that glucocorticoid receptors expression is influenced by melatonin administration. Melatonin preserves mitochondrial homeostasis, (<xref ref-type="bibr" rid="R42"><sup>42</sup></xref>) reduces free radical generation by enhancing mitochondrial glutathione levels, and safeguards proton potential and ATP synthesis by stimulating complex 1 and complex 4 activities (<xref ref-type="bibr" rid="R43"><sup>43</sup></xref>). Melatonin is well known for its functional interactions with the neuroendocrine axis and with the circadian biorhythms (<xref ref-type="bibr" rid="R16"><sup>16</sup></xref>). Very recently it has also been found to have neuroprotective and neuroregenrative effects in models of neuronal cell deaths in which excitotoxins are involved (<xref ref-type="bibr" rid="R44"><sup>44</sup></xref>). Melatonin plays important role in many different physiological processes including, regulation of circadian rhythms, sleep promotion (<xref ref-type="bibr" rid="R45"><sup>45</sup></xref>) and reproduction (<xref ref-type="bibr" rid="R46"><sup>46</sup></xref>). It has an anti-inflammatory effect against ischemia/ reperfusion injury and stroke models (<xref ref-type="bibr" rid="R47"><sup>47</sup></xref>) Melatonin is also effective in protecting the nuclear DNA and its associated histone proteins (<xref ref-type="bibr" rid="R48"><sup>48</sup></xref>). Human lymphocytes also produce melatonin when attacked by a mitogen that is Phytohaemagglutinin (PHA). One of the main targets of melatonin is thymus-central organ of immune system, (<xref ref-type="bibr" rid="R49"><sup>49</sup></xref>) it plays an important role in immuno-neuro-endocrine network (<xref ref-type="bibr" rid="R38"><sup>38</sup></xref>) and Immunocancer therapy (<xref ref-type="bibr" rid="R50"><sup>50</sup></xref>). Neuroprotective and neuroregenrative effect of Melatonin have been tested and are being further studied for establishing it, as a drug molecule to be used in neurodegenerative diseases. When administered exogenously it suppress estrogen synthesis, possibly through reducing luteinizing hormone and FSH secretion. It also interferes with binding of estrogen to its receptors (<xref ref-type="bibr" rid="R22"><sup>22</sup></xref>). Antagonism has been established between melatonin and the reproductive hormones. Melatonin exerts inhibitory effect at various levels of hypothalamic pituitary gonadal axis in brain. The effect of melatonin on reproductive systems can be summarized by saying that it is anti-gonadotropic (<xref ref-type="bibr" rid="R25"><sup>25</sup></xref>). In other words, melatonin inhibits the secretion of the gonadotropic hormones, luteinizing hormone and follicle-stimulating hormone from the anterior pituitary. Much of this inhibitory effect seems due to inhibition of gonadotropin-releasing hormone from the hypothalamus, which is necessary for secretion of the anterior pituitary hormones. One practical application of melatonin's role in controlling seasonal reproduction is found in its use to artificially manipulate cycles in seasonal breeders.</p>
</sec>
<sec id="s9" sec-type="Powerful Antioxidant">
<title>Powerful Antioxidant</title>
<p>It was 'lanas' who first suggested that melatonin may have a role in scavenging free radicals(<xref ref-type="bibr" rid="R51"><sup>51</sup></xref>). Melatonin has been shown to be highly effective in reducing oxidative damage in the central nervous system(<xref ref-type="bibr" rid="R52"><sup>52</sup></xref>) this efficacy derives from its ability to directly scavenge a number of free radicals(<xref ref-type="bibr" rid="R16"><sup>16</sup></xref>) and to function as an indirect antioxidant(<xref ref-type="bibr" rid="R53"><sup>53</sup></xref>). In particular melatonin detoxifies the free radicals via electron donation (<xref ref-type="bibr" rid="R54"><sup>54</sup></xref>). Its function as a free radical scavenger is likely facilitated by the ease with which it crosses the morphological barriers like the blood brain barriers to enter the nerve cells and sub cellular compartments (<xref ref-type="bibr" rid="R55"><sup>55</sup></xref>). It scavenges hydroxyl, carbonate and various organic radicals, peroxynitrite and other reactive nitrogen species (<xref ref-type="bibr" rid="R56"><sup>56</sup></xref>). Melatonyl radicals formed by scavenging combine with and, thereby, detoxify superoxide anions in processes terminating the radical reaction chains. Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels (<xref ref-type="bibr" rid="R52"><sup>52</sup></xref>). Definitive evidence that melatonin function as a direct scavenger of hydroxyl radical (OH) was provided by Tan et al., in 1993. OH- is widely accepted as the most damaging molecule endogenously produced in aerobic organisms. The OH radical mutilates any molecule in the vicinity of where it is produced (<xref ref-type="bibr" rid="R57"><sup>57</sup></xref>). In <italic>in vitro</italic> and <italic>in vivo</italic> experiments, melatonin has been found to protect cells, tissues and organs against oxidative damages induced by a variety of free radicals generating agents and processes, including the cyanide poisoning, glutathione depletion, ischemia reperfusion, kainic acid induced excitotoxicity and MPTP (1 methyl-4phenyl 1,2,3,6-tetrahydropyridine) (<xref ref-type="bibr" rid="R58"><sup>58</sup></xref>). Melatonin as an antioxidant protects the nuclear DNA, membrane lipid and cytosolic proteins from oxidative damage but is also reported to alter the activities of enzymes that improve the total antioxidative defense capacity of the organism (<xref ref-type="bibr" rid="R59"><sup>59</sup></xref>). Melatonin not only stimulates 'antioxidant cascade' but also scavenges resulting metabolite effectively. They claimed that melatonin was more efficient peroxyl radical scavenger as compared to vitamin E.</p>
</sec>
<sec id="s10" sec-type="Melatonin's Action on antioxidative enzymes and gene expression">
<title>Melatonin's Action on antioxidative enzymes and gene expression</title>
<p>Melatonin stimulates several important antioxidative enzymes, their activity or their gene expression (<xref ref-type="bibr" rid="R60"><sup>60</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R61"><sup>61</sup></xref>) including Super Oxide Dismutase (SOD) Glutathione peroxidase (GPx)(<xref ref-type="bibr" rid="R62"><sup>62</sup></xref>) and Glutathione reductase.(GRx). Experimental evidences show that melatonin promotes activity of GRx, thereby helping to maintain high levels of reduced glutathione. At a molecular level melatonin has been reported to increase tissue levels of messenger RNA for both manganese SOD as well as copper SOD. It was also documented in the same study that messenger RNA levels for GSH-Px were also augmented after melatonin administration. The amphophilic property of melatonin and importance as a vital antioxidant depends on several characteristics such as: its lipophilic and hydrophilic nature, its ability to cross all barriers with ease and its availability to all tissues and cells(<xref ref-type="bibr" rid="R52"><sup>52</sup></xref>). Levels of melatonin are two to three times of magnitude higher than maximal blood melatonin concentration in cerebrospinal fluid (<xref ref-type="bibr" rid="R63"><sup>63</sup></xref>). Melatonin efficacy was compared with classical antioxidants in terms of pharmacologically protective agent against free radical damage and the in vivo studies reported that melatonin was found to be more effective at a very lower dose than other antioxidants (<xref ref-type="bibr" rid="R64"><sup>64</sup></xref>).</p>
</sec>
<sec id="s11" sec-type="The life extender role">
<title>The life extender role</title>
<p>Increased melatonin has significantly increased life span in the test animals. The systemic administration of melatonin stimulated neurogenesis, improved neuronal survival rate and facilitated behavioral recovery after transient focal cerebral ischemia in mice (<xref ref-type="bibr" rid="R65"><sup>65</sup></xref>). It was shown that melatonin increases cell proliferation in the dentate gyrus region of maternally separated rats (<xref ref-type="bibr" rid="R66"><sup>66</sup></xref>). Melatonin reduces the oxidative damage in the central nervous system effectively and improves the life of neurons due to its ease with which it crosses the blood brain barrier (<xref ref-type="bibr" rid="R35"><sup>35</sup></xref>). Melatonin has antidepressant properties and the hormone can be recommended to improve the quality of life of cancer patients on chemotherapy (<xref ref-type="bibr" rid="R67"><sup>67</sup></xref>). It has been proved that melatonin improves the quality of sleep and is helpful in maintaining the biorhythms at a pace (<xref ref-type="bibr" rid="R45"><sup>45</sup></xref>).</p>
</sec>
<sec id="s12" sec-type="Melatonin and the neurodegenerative diseases">
<title>Melatonin and the neurodegenerative diseases</title>
<p>Melatonin is a free radical scavenger, an antioxidant and immunomodulatory agent. Antioxidant properties of melatonin are connected with its neuroprotective activity in several degenerative disorders (<xref ref-type="bibr" rid="R68"><sup>68</sup></xref>). The etiology of the neurodegenerative diseases, which are characterized by the progressive and irreversible destruction of specific neuronal populations, is complex and multifactorial (<xref ref-type="bibr" rid="R69"><sup>69</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R70"><sup>70</sup></xref>). One of causes of neurodegenerative damage in the nervous system is oxidative injury, which results from an imbalance between free radical formation (<xref ref-type="bibr" rid="R71"><sup>71</sup></xref>) and antioxidative mechanisms (<xref ref-type="bibr" rid="R72"><sup>72</sup></xref>). The efficacy of melatonin in the inhibition of the oxidative stress was estimated (<xref ref-type="bibr" rid="R73"><sup>73</sup></xref>) in various neurodegenerative disorders whose pathogenesis is associated with cytotoxic activity of free oxygen radicals, such as Alzheimer's or Parkinson's disease (<xref ref-type="bibr" rid="R74"><sup>74</sup></xref>). The experimental findings related to the neuroprotective role of melatonin in particular, focuses on research directed at models of Huntington's disease, Alzheimer's disease (<xref ref-type="bibr" rid="R75"><sup>75</sup></xref>) and Parkinsonism (<xref ref-type="bibr" rid="R43"><sup>43</sup></xref>). The decline in melatonin production in aged individuals has been suggested as one of the primary contributing factors for the development of age-associated (<xref ref-type="bibr" rid="R76"><sup>76</sup></xref>) neurodegenerative diseases, e.g., Alzheimer's disease (<xref ref-type="bibr" rid="R77"><sup>77</sup></xref>). Melatonin has been shown to be effective in arresting neurodegenerative phenomenon seen in experimental models of Alzheimer's disease, Parkinsonism and ischemic stroke. Melatonin preserves mitochondrial homeostasis, reduces free radical generation, e.g., by enhancing mitochondrial glutathione levels, and safeguards proton potential (<xref ref-type="bibr" rid="R78"><sup>78</sup></xref>) and ATP synthesis by stimulating complex IV and I activities (<xref ref-type="bibr" rid="R52"><sup>52</sup></xref>). Therapeutic trials with melatonin have been effective in slowing the progression of Alzheimer's disease but not of Parkinson's disease. Melatonin's efficacy in combating free radical damage in the brain suggests that it may be a valuable therapeutic agent in the treatment of cerebral edema after traumatic brain injury. Different patterns of melatonin concentrations is observed at different stages of neurodegenerative diseases related to the age and the secretion patterns are being studied for the onset of neurodegenerative diseases (<xref ref-type="bibr" rid="R19"><sup>19</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R79"><sup>79</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R80"><sup>80</sup></xref>)</p>
</sec>
<sec id="s13" sec-type="Recent trends in Melatonin research">
<title>Recent trends in Melatonin research</title>
<p>The recent research has been focused largely on the neuroprotective and neuroregenrative properties of Melatonin (<xref ref-type="bibr" rid="R81"><sup>81</sup></xref>). Melatonin is a powerful antioxidant, lack serious toxicity and its natural occurrence has evoked hopes that it might be used as a promising drug in the near future for neurological disorders (<xref ref-type="bibr" rid="R82"><sup>82</sup></xref><sup>,</sup> <xref ref-type="bibr" rid="R83"><sup>83</sup></xref>). Melatonin directly scavenge free radicals, stabilizes and protects the nervous system. The recent researches have shown that melatonin could be wonder drug in near future for various ailments. (<xref ref-type="bibr" rid="R84"><sup>84</sup></xref>) Melatonin versatility and combination of actions is making it a highly effective pharmacological agent for neuroprotection, neuroregenration and to treat and cure the neurodegenerative disorders, brain tumors, and cancers (<xref ref-type="bibr" rid="R85"><sup>85</sup></xref>) as it is one of the safest product around with no observed late side effects or consequences. In recent research work melatonin is shown to prevent the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and nitridergic pathways (<xref ref-type="bibr" rid="R86"><sup>86</sup></xref>) Scientist have proved melatonin's role in cell proliferation in the dentate gyrus region of maternally separated rats (<xref ref-type="bibr" rid="R66"><sup>66</sup></xref>). Researches are studying the mechanism of neuronal plasticity and stressor toxicity during aging and role of melatonin during these processes. Melatonin's role in ischemia reperfusion injury has been reported (<xref ref-type="bibr" rid="R65"><sup>65</sup></xref>) that pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle brain cerebral artery occlusion stroke model. The recent studies investigated whether systemic administration of melatonin stimulates endogenous neurogenesis, improves neuronal survival and facilitates behavioral recovery after transient focal cerebral ischemia in mice. The results demonstrated that, in all the evaluated regions of the brain including cortex, striatum, hippocampus and sub ventricular zone the number of proliferating cells of neural lineage was found significantly higher for melatonin treated animals than for the control groups. The number of surviving neurons was also significantly higher in melatonin treated animals (<xref ref-type="bibr" rid="R65"><sup>65</sup></xref>). Researches are going on to investigate the role of melatonin in early developmental events of adult neurogenesis, apoptosis and neurophilic migration in adult hippocampus region. Melatonin pharmacological role as an agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinson's disease needs to be generated before the drug can find place in neurology clinics (<xref ref-type="bibr" rid="R87"><sup>87</sup></xref>). The experimental findings are related to the neuroprotective role of melatonin and its high effectiveness in scavenging a number of free radicals such as the peroxyl radical, peroxy nitrite anion, nitric oxide, singlet oxygen etc. and reducing the oxidative damage in cells. The role of physiological levels of melatonin in forestalling oxidative damage in the brain is currently being tested.</p>
<p>In our laboratory attempt has been made to investigate the neuroprotective effects of melatonin. The results were compared to the herbal formulations known for their potent role in neuroprotection and melatonin was found to be more effective. Studies are being carried to assess the action of melatonin on the antioxidant enzyme profiles.</p>
</sec>
</body>
<back>
<ref-list>
<title>References:</title>
<ref id="R01">
<label>1</label>
<element-citation publication-type="journal">
<name><surname>Arendt</surname> <given-names>J</given-names></name> <article-title>Melatonin, circadian rhythms, and sleep</article-title> <source>N Engl J Med</source> <year>2000</year> <volume>343</volume> <fpage>1114</fpage> <lpage>16</lpage></element-citation></ref>
<ref id="R02">
<label>2</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>The melatonin rhythm: both a clock and a calendar</article-title> <source>Experimenta</source> <year>1993</year> <volume>49</volume> <fpage>654</fpage> <lpage>64</lpage></element-citation></ref>
<ref id="R03">
<label>3</label>
<element-citation publication-type="journal">
<name><surname>Dawson</surname><given-names>D</given-names></name> <name><surname>Armstrong</surname> <given-names>SM</given-names></name> <article-title>Chronobiotics-drugs that shift rhythm</article-title> <source>Pharmacol Ther</source> <year>1996</year> <volume>69</volume> <fpage>15</fpage> <lpage>36</lpage></element-citation></ref>
<ref id="R04">
<label>4</label>
<element-citation publication-type="journal">
<name><surname>Van Someren</surname> <given-names>EJ</given-names></name> <article-title>Circadian and sleep disturbance in the elderly</article-title> <source>Exp Gerontol</source> <year>2000</year> <volume>35</volume> <fpage>1229</fpage> <lpage>37</lpage></element-citation></ref>
<ref id="R05">
<label>5</label>
<element-citation publication-type="journal">
<name><surname>Cavallo</surname> <given-names>A</given-names></name> <article-title>The pineal gland in human beings: relevance to pediatrics</article-title> <source>J Pediatr</source> <year>1993</year> <volume>123</volume> <fpage>843</fpage> <lpage>51</lpage></element-citation></ref>
<ref id="R06">
<label>6</label>
<element-citation publication-type="journal">
<name><surname>Iguchi</surname><given-names>H</given-names></name> <name><surname>Kato</surname><given-names>KI</given-names></name> <name><surname>Ibayashi</surname> <given-names>H</given-names></name> <article-title>Age-dependent reduction in serum melatonin concentrations in healthy human subjects</article-title> <source>J Clin Endocrinol Metab</source> <year>1982</year> <volume>55</volume> <fpage>27</fpage> <lpage>29</lpage></element-citation></ref>
<ref id="R07">
<label>7</label>
<element-citation publication-type="journal">
<name><surname>Ceung</surname><given-names>KM</given-names></name> <name><surname>Lu</surname><given-names>DS</given-names></name> <name><surname>Poon</surname><given-names>AM</given-names></name> <etal/> <article-title>Effect of melatonin in suppression on scoliosis development in chickens by either constant light or surgical pinealectomy</article-title> <source>Spine</source> <year>2003</year> <volume>28</volume> <fpage>1941</fpage> <lpage>44</lpage></element-citation></ref>
<ref id="R08">
<label>8</label>
<element-citation publication-type="journal">
<name><surname>Zeiter</surname><given-names>JM</given-names></name> <name><surname>Daniels</surname><given-names>JE</given-names></name> <name><surname>Duffy</surname><given-names>JF</given-names></name> <etal/> <article-title>Do plasma melatonin concentrations decline with age?</article-title> <source>Am J Med</source> <year>1999</year> <volume>107</volume> <fpage>432</fpage> <lpage>36</lpage></element-citation></ref>
<ref id="R09">
<label>9</label>
<element-citation publication-type="journal">
<name><surname>Cavallo</surname> <given-names>A</given-names></name> <article-title>Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages</article-title> <source>Neuroendocrinology</source> <year>1992</year> <volume>55</volume> <fpage>372</fpage> <lpage>79</lpage></element-citation></ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<name><surname>Swaab</surname><given-names>DF</given-names></name> <name><surname>Fliers</surname><given-names>E</given-names></name> <name><surname>Partiman</surname> <given-names>TS</given-names></name> <article-title>The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia</article-title> <source>Brain Res</source> <year>1985</year> <volume>342</volume> <fpage>37</fpage> <lpage>44</lpage></element-citation></ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>Pineal melatonin: cell biology of its synthesis and of its physiological interactions</article-title> <source>Endocr Rev</source> <year>1991</year> <volume>12</volume> <fpage>151</fpage> <lpage>80</lpage></element-citation></ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<name><surname>Van-Someren</surname> <given-names>EJW</given-names></name> <article-title>Circadian rhythms and sleep in ageing man</article-title> <source>Chronobiology Int</source> <year>2000</year> <volume>17</volume> <fpage>233</fpage> <lpage>43</lpage></element-citation></ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<name><surname>Tricoire</surname><given-names>H</given-names></name> <name><surname>Locatelli</surname><given-names>A</given-names></name> <name><surname>Chemineau</surname><given-names>P</given-names></name> <name><surname>Malpaux</surname> <given-names>B</given-names></name> <article-title>Melatonin enters the cerebrospinal fluid through the pineal recess</article-title> <source>Endocrinology</source> <year>2000</year> <volume>143</volume> <fpage>84</fpage> <lpage>90</lpage></element-citation></ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<name><surname>Claustrat</surname><given-names>B</given-names></name> <name><surname>Brun</surname><given-names>J</given-names></name> <name><surname>Chazot</surname> <given-names>G</given-names></name> <article-title>The basic physiology and pathophysiology of melatonin</article-title> <source>Sleep Med Rev</source> <year>2005</year> <volume>9</volume> <fpage>11</fpage><lpage>24</lpage></element-citation></ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname> <given-names>DX</given-names></name> <article-title>What constitute a physiological concentration of melatonin?</article-title> <source>J Pineal Res</source> <year>2003</year> <volume>34</volume> <fpage>79</fpage> <lpage>80</lpage></element-citation></ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname> <given-names>DX</given-names></name> <article-title>Role of CSF in the transport of melatonin</article-title> <source>J Pineal Res</source> <year>2002</year> <volume>33</volume><fpage>61</fpage></element-citation></ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<name><surname>Hardeland</surname><given-names>R</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Poeggler</surname><given-names>B</given-names></name> <name><surname>Tan</surname> <given-names>DX</given-names></name> <article-title>The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances</article-title> <source>Neurosci Biobehav Rev</source> <year>1993</year> <volume>17</volume> <fpage>347</fpage> <lpage>57</lpage></element-citation></ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<name><surname>Catala</surname><given-names>MD</given-names></name> <name><surname>Quay</surname><given-names>W</given-names></name> <name><surname>Vibat</surname><given-names>CRT</given-names></name> <name><surname>Timiras</surname> <given-names>PS</given-names></name> <article-title>Hypothyroidism and rehabilitation of day and night melatonin levels in pineal, hypothalamus and serum of male rats</article-title> <source>Neuroendocrinol Lett</source> <year>1987</year> <volume>9</volume> <fpage>379</fpage> <lpage>88</lpage></element-citation></ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<name><surname>Skene</surname><given-names>DJ</given-names></name> <name><surname>Viven-Roels</surname><given-names>B</given-names></name> <name><surname>Sparks Hunsaker</surname><given-names>JC</given-names></name> <etal/> <article-title>Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease</article-title> <source>Brain Res</source> <year>1990</year> <volume>528</volume> <fpage>170</fpage> <lpage>74</lpage></element-citation></ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<name><surname>Cardinali</surname><given-names>DP</given-names></name> <name><surname>Rosenstein</surname><given-names>RE</given-names></name> <name><surname>Golombek</surname><given-names>DA</given-names></name> <etal/> <article-title>Melatonin binding sites in brain: single or multiple?</article-title> <source>Adv Pineal Res</source> <year>1991</year> <volume>5</volume> <fpage>159</fpage> <lpage>65</lpage></element-citation></ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<name><surname>Witt-Enderby</surname><given-names>PA</given-names></name> <name><surname>Bennett</surname><given-names>J</given-names></name> <name><surname>Jarzynka</surname><given-names>MJ</given-names></name> <etal/> <article-title>Melatonin receptors and their regulation: biochemical and structural mechanisms</article-title> <source>Life Sci</source> <year>2003</year> <volume>72</volume> <fpage>2183</fpage> <lpage>98</lpage></element-citation></ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<name><surname>Reppert</surname><given-names>SM</given-names></name> <name><surname>Godson</surname><given-names>C</given-names></name> <name><surname>Mahle</surname><given-names>CD</given-names></name> <etal/> <article-title>Molecular characterization of a second melatonin receptor expressed in human retina and brain: the mellb melatonin receptor</article-title> <source>Proc Nati Acad Sci USA</source> <year>1995</year> <volume>92</volume> <fpage>8734</fpage> <lpage>38</lpage></element-citation></ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<name><surname>Viswanathan</surname><given-names>M</given-names></name> <name><surname>Laitinem</surname><given-names>JT</given-names></name> <name><surname>Saavedra</surname> <given-names>JM</given-names></name> <article-title>Expression of melatonin receptors in arteries involved in thermoregulation</article-title> <source>Proc Natl Acad Sci USA</source> <year>1990</year> <volume>87</volume> <fpage>6200</fpage> <lpage>3</lpage></element-citation></ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<name><surname>Dubocovich</surname><given-names>ML</given-names></name> <name><surname>Masana</surname><given-names>MI</given-names></name> <name><surname>Benloucif</surname> <given-names>S</given-names></name> <article-title>Molecular pharmacology and function of melatonin receptor subtypes</article-title> <source>Adv Exp Med Biol</source> <year>1999</year> <volume>460</volume> <fpage>181</fpage> <lpage>90</lpage></element-citation></ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<name><surname>Reppert</surname><given-names>SM</given-names></name> <name><surname>Weaver</surname><given-names>DR</given-names></name> <name><surname>Ebisawa</surname> <given-names>T</given-names></name> <article-title>Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses</article-title> <source>Neuron</source> <year>1994</year> <volume>13</volume> <fpage>1177</fpage> <lpage>85</lpage></element-citation></ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<name><surname>Wiechmann</surname><given-names>AF</given-names></name> <article-title>Melatonin parallels in pineal gland and retina</article-title> <source>Exp Eye Res</source> <year>1986</year> <volume>42</volume> <fpage>507</fpage> <lpage>27</lpage></element-citation></ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Manchester</surname><given-names>LC</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <etal/> <article-title>High physiological levels of melatonin in the bile of mammals</article-title> <source>Life Sci</source> <year>1999</year> <volume>65</volume> <fpage>2523</fpage> <lpage>29</lpage></element-citation></ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<name><surname>Conti</surname><given-names>A</given-names></name> <name><surname>Conconi</surname><given-names>S</given-names></name> <name><surname>Hertens</surname><given-names>E</given-names></name> <etal/> <article-title>Evidence for melatonin synthesis in mouse and human bone marrow cells</article-title> <source>J Pineal Res</source> <year>2000</year> <volume>28</volume> <fpage>193</fpage> <lpage>202</lpage></element-citation></ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<name><surname>Hardeland</surname><given-names>R</given-names></name> <name><surname>Fuhrberg</surname> <given-names>B</given-names></name> <article-title>Ubiquitious, melatonin: presence and effects in uncills, plants and animals</article-title> <source>Trends comp Biochem Physiol</source> <year>1996</year> <volume>2</volume> <fpage>25</fpage> <lpage>45</lpage></element-citation></ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<name><surname>Dubbels</surname><given-names>R</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Klenke</surname><given-names>E</given-names></name> <etal/> <article-title>Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry</article-title> <source>J Pineal Res</source> <year>1995</year> <volume>18</volume> <fpage>28</fpage> <lpage>31</lpage></element-citation></ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<name><surname>Hardeland</surname><given-names>R</given-names></name> <name><surname>Pandi-Perumal</surname> <given-names>SR</given-names></name> <article-title>Melatonin, a potent agent in antioxidative defence: actions as a natural food constituteny, gastrointestinal factor, drug and prodrug</article-title> <source>Nutr Metab</source> <year>2005</year> <volume>2</volume> <fpage>22</fpage></element-citation></ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<name><surname>Hattori</surname><given-names>A</given-names></name> <name><surname>Migitaka</surname><given-names>H</given-names></name> <name><surname>Ligo</surname> <given-names>M</given-names></name> <article-title>Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates</article-title> <source>Biochem Mol Biol Int</source> <year>1995</year> <volume>35</volume> <fpage>627</fpage> <lpage>34</lpage></element-citation></ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Manchester</surname><given-names>LC</given-names></name> <etal/> <article-title>Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger</article-title> <source>Curr Top Med Chem</source> <year>2002</year> <volume>2</volume> <fpage>181</fpage> <lpage>97</lpage></element-citation></ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<name><surname>Pang</surname><given-names>SF</given-names></name> <name><surname>Brown</surname> <given-names>G</given-names></name> <article-title>Regional concentration of melatonin in rat brain in the light and dark period</article-title> <source>Life Sci</source> <year>1983</year> <volume>33</volume> <fpage>1100</fpage> <lpage>204</lpage></element-citation></ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<name><surname>Abe</surname><given-names>M</given-names></name> <name><surname>Itoh</surname><given-names>MT</given-names></name> <name><surname>Miyata</surname><given-names>M</given-names></name> <etal/> <article-title>Circadian rhythm of serotonin N-acetyltransferase activity in rat lens</article-title> <source>Exp Eye Res</source> <year>2000</year> <volume>70</volume> <fpage>805</fpage> <lpage>08</lpage></element-citation></ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<name><surname>Poeggeler</surname><given-names>B</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Hardeland</surname><given-names>R</given-names></name> <etal/> <article-title>Melatonin and structurally related endogenous indoles act as potent electron donors and radical scavengers in vitro</article-title> <source>Redox Rep</source> <year>1996</year> <volume>2</volume> <fpage>179</fpage> <lpage>84</lpage></element-citation></ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<name><surname>Anton Tay</surname><given-names>F</given-names></name> <name><surname>Dfaz</surname><given-names>JL</given-names></name> <name><surname>Fernandez-guardiola</surname> <given-names>A</given-names></name> <article-title>On the effect of melatonin upon human brain. Its possible therapeutic implications</article-title> <source>Life Sci</source> <year>1971</year> <volume>10</volume> <fpage>841</fpage> <lpage>50</lpage></element-citation></ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<name><surname>Skwarlo-Sonta</surname> <given-names>K</given-names></name> <article-title>Melatonin in immunity: comparative aspects</article-title> <source>Neuroendocrinol Lett</source> <year>2002</year> <volume>1</volume> <fpage>61</fpage> <lpage>66</lpage></element-citation></ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<name><surname>Ressmeyer</surname><given-names>AR</given-names></name> <name><surname>Mayo</surname><given-names>JC</given-names></name> <name><surname>Zelosko</surname><given-names>V</given-names></name> <etal/> <article-title>Antioxidant properties of melatonin metabolite N'-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction</article-title> <source>Redox Rep</source> <year>2003</year> <volume>8</volume> <fpage>205</fpage> <lpage>13</lpage></element-citation></ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<name><surname>Pappola</surname><given-names>MA</given-names></name> <name><surname>Chyan</surname><given-names>Y</given-names></name> <name><surname>Poeggeler</surname><given-names>B</given-names></name> <etal/> <article-title>Alzheimer B protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin</article-title> <source>J Pineal Res</source> <year>1999</year> <volume>27</volume> <fpage>226</fpage> <lpage>29</lpage></element-citation></ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<name><surname>Menendez-Pelaez</surname><given-names>A</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization</article-title> <source>J Pineal Res</source> <year>1993</year> <volume>15</volume> <fpage>59</fpage> <lpage>6</lpage></element-citation></ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Manchester</surname><given-names>LC</given-names></name> <name><surname>Sawi El</surname> <given-names>MR</given-names></name> <article-title>Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for ageing</article-title> <source>Ann N Y Acad Sci</source> <year>2002</year> <volume>959</volume> <fpage>238</fpage> <lpage>50</lpage></element-citation></ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<name><surname>Srinivasan</surname><given-names>V</given-names></name> <name><surname>Pandi-Perumal</surname><given-names>SR</given-names></name> <name><surname>Maestroni</surname><given-names>GJM</given-names></name> <etal/> <article-title>Role of melatonin in neurodegenerative diseases</article-title> <source>Neurotox Res</source> <year>2005</year> <volume>7</volume> <fpage>293</fpage> <lpage>318</lpage></element-citation></ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<name><surname>Zizapel</surname> <given-names>N</given-names></name> <article-title>Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting</article-title> <source>Cell Mol Neurobiol</source> <year>2001</year> <volume>21</volume> <fpage>605</fpage> <lpage>16</lpage></element-citation></ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<name><surname>Wurtman</surname><given-names>RJ</given-names></name> <name><surname>Zhdanova</surname> <given-names>I</given-names></name> <article-title>Improvement of sleep quality by melatonin</article-title> <source>Lancet</source> <year>1995</year> <volume>346</volume> <fpage>1491</fpage></element-citation></ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>The pineal and its hormone in the control of reproduction in mammals</article-title> <source>Endocr Rev</source> <year>1980</year> <volume>1</volume> <fpage>109</fpage><lpage>31</lpage></element-citation></ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname> <given-names>DX</given-names></name> <article-title>Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart</article-title> <source>Cardiovasc Res</source> <year>2003</year> <volume>58</volume> <fpage>10</fpage> <lpage>19</lpage></element-citation></ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<name><surname>Anton Tay</surname><given-names>F</given-names></name> <name><surname>Dfaz</surname><given-names>JL</given-names></name> <name><surname>Fernandez-guardiola</surname> <given-names>A</given-names></name> <article-title>On the effect of melatonin upon human brain. Its possible therapeutic implications</article-title> <source>Life Sci</source> <year>1971</year> <volume>10</volume> <fpage>841</fpage> <lpage>50</lpage></element-citation></ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<name><surname>Esquifino</surname><given-names>Al</given-names></name> <name><surname>Pandi-Perumal</surname><given-names>SR</given-names></name> <name><surname>Cardinali</surname><given-names>DR</given-names></name> <article-title>Circadian organization of the immune response: a role for melatonin</article-title> <source>Ciln Appi Immunol Rev</source> <year>2004</year> <volume>4</volume> <fpage>423</fpage> <lpage>33</lpage></element-citation></ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<name><surname>Guerrero</surname><given-names>JM</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>Melatonin-immune system relationships</article-title> <source>Curr Top Med Chem</source> <year>2002</year> <volume>2</volume> <fpage>167</fpage> <lpage>79</lpage></element-citation></ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<name><surname>Lanas</surname><given-names>O</given-names></name> <name><surname>Olinescu</surname><given-names>R</given-names></name> <name><surname>Badescu</surname> <given-names>I</given-names></name> <article-title>Melatonin involvement in oxidation processes</article-title> <source>Endocrinologie</source> <year>1991</year> <volume>29</volume> <fpage>147</fpage> <lpage>53</lpage></element-citation></ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname> <given-names>RJ</given-names></name> <article-title>Oxidative damage in the central nervous system: protection by melatonin</article-title> <source>Prog Neurobiol</source> <year>1998</year> <volume>56</volume> <fpage>359</fpage> <lpage>84</lpage></element-citation></ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<name><surname>Srinivasan</surname> <given-names>V</given-names></name> <article-title>Melatonin, oxidative stress and ageing</article-title> <source>Curr sci</source> <year>1999</year> <volume>76</volume> <fpage>46</fpage> <lpage>54</lpage></element-citation></ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Manchester</surname><given-names>LC</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <etal/> <article-title>Significance of melatonin in antioxidative defense system: reactions and products</article-title> <source>Biol Signals Recept</source> <year>2000</year> <volume>9</volume> <fpage>137</fpage> <lpage>59</lpage></element-citation></ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Leon</surname><given-names>J</given-names></name> <etal/> <article-title>When melatonin gets on your nerves its beneficial actions in experimental models of stroke. Exp Biol Med</article-title> <year>2005</year> <volume>230</volume> <fpage>104</fpage> <lpage>17</lpage></element-citation></ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Manchester</surname><given-names>LC</given-names></name> <etal/> <article-title>Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger</article-title> <source>Curr Top Med Chem</source> <year>2002</year> <volume>2</volume> <fpage>181</fpage> <lpage>97</lpage></element-citation></ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Chen</surname><given-names>LD</given-names></name> <name><surname>Poeggeler</surname><given-names>B</given-names></name> <etal/> <article-title>Melatonin: a potent endogenous hydroxyl radical scavenger</article-title> <source>Endocr J</source> <year>1993</year> <volume>1</volume> <fpage>57</fpage> <lpage>60</lpage></element-citation></ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<name><surname>Floreani</surname><given-names>M</given-names></name> <name><surname>Skaper</surname><given-names>SD</given-names></name> <name><surname>Facci</surname><given-names>L</given-names></name> <etal/> <article-title>Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues</article-title> <source>Faseb J</source> <year>1997</year> <volume>11</volume> <fpage>1309</fpage> <lpage>15</lpage></element-citation></ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Acuna-Castroviejo</surname><given-names>D</given-names></name> <name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Burkhardt</surname> <given-names>S</given-names></name> <article-title>Free radical &#x2013; mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system</article-title> <source>Ann NY Acad Sci</source> <year>2001</year> <volume>939</volume> <fpage>200</fpage> <lpage>15</lpage></element-citation></ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<name><surname>Carlberg</surname> <given-names>C</given-names></name> <article-title>Gene regulation by melatonin</article-title> <source>Ann NY Acad Sci</source> <year>2000</year> <volume>917</volume> <fpage>387</fpage> <lpage>96</lpage></element-citation></ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<name><surname>Rodriguez</surname><given-names>C</given-names></name> <name><surname>Mayo</surname><given-names>JC</given-names></name> <name><surname>Sainz</surname><given-names>RM</given-names></name> <etal/> <article-title>Regulation of antioxidant enzymes: a significant role for melatonin</article-title> <source>J Pineal Res</source> <year>2004</year> <volume>36</volume> <fpage>1</fpage> <lpage>9</lpage></element-citation></ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<name><surname>Barlow-Walden</surname><given-names>LR</given-names></name> <name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Abe</surname><given-names>M</given-names></name> <etal/> <article-title>Melatonin stimulates brain glutathione peroxidase activity</article-title> <source>Neurochem Int</source> <year>1995</year> <volume>26</volume> <fpage>497</fpage> <lpage>502</lpage></element-citation></ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<name><surname>Skinner</surname><given-names>DC</given-names></name> <name><surname>Malpaux</surname> <given-names>B</given-names></name> <article-title>High Melatonin concentration in third ventricular cerebrospinal fluid are not due to galen vein blood recirculating through the choroids plexus</article-title> <source>Endocrinology</source> <year>1999</year> <volume>140</volume> <fpage>4399</fpage> <lpage>05</lpage></element-citation></ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<name><surname>Montilla</surname><given-names>P</given-names></name> <name><surname>Cruz</surname><given-names>A</given-names></name> <name><surname>Padillo</surname><given-names>FJ</given-names></name> <etal/> <article-title>Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats</article-title> <source>J Pineal Res</source> <year>2001</year> <volume>31</volume> <fpage>138</fpage> <lpage>44</lpage></element-citation></ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<name><surname>Kilic</surname><given-names>E</given-names></name> <name><surname>Kilic</surname><given-names>V</given-names></name> <name><surname>Yulug</surname><given-names>B</given-names></name> <etal/> <article-title>Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator</article-title> <source>J Pineal Res</source> <year>2004</year> <volume>36</volume> <fpage>171</fpage> <lpage>76</lpage></element-citation></ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<name><surname>Kim</surname><given-names>M</given-names></name> <name><surname>Kim</surname><given-names>HK</given-names></name> <name><surname>Kim</surname><given-names>BS</given-names></name> <name><surname>Yim</surname> <given-names>S</given-names></name> <article-title>Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats</article-title> <source>J Pineal Res</source> <year>2004</year> <volume>37</volume> <fpage>193</fpage> <lpage>97</lpage></element-citation></ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<name><surname>Lissoni</surname><given-names>P</given-names></name> <name><surname>Barni</surname><given-names>S</given-names></name> <name><surname>Meregalli</surname><given-names>S</given-names></name> <etal/> <article-title>Modulation of cancer.endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patient progressing under tamoxifen alone</article-title> <source>British J Cancer</source> <year>1995</year> <volume>71</volume> <fpage>854</fpage> <lpage>56</lpage></element-citation></ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<name><surname>Urano</surname><given-names>S</given-names></name> <name><surname>Sato</surname><given-names>Y</given-names></name> <name><surname>Otonari</surname><given-names>T</given-names></name> <etal/> <article-title>Ageing and oxidative stress in neurodegenration</article-title> <source>Bio Factors</source> <year>1998</year> <volume>7</volume> <fpage>103</fpage> <lpage>12</lpage></element-citation></ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<name><surname>Emerit</surname><given-names>J</given-names></name> <name><surname>Edeas</surname><given-names>M</given-names></name> <name><surname>Bricaire</surname> <given-names>F</given-names></name> <article-title>Neurodegenerative diseases and oxidative stress</article-title> <source>Biomed Pharmacother</source> <year>2004</year> <volume>58</volume> <fpage>39</fpage> <lpage>46</lpage></element-citation></ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<name><surname>Srinivasan</surname> <given-names>V</given-names></name> <article-title>Melatonin oxidative stress and neurodegenerative diseases</article-title> <source>Indian J Exp Biol</source> <year>2002</year> <volume>40</volume> <fpage>668</fpage> <lpage>79</lpage></element-citation></ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<name><surname>St George-Hyslop</surname><given-names>PH</given-names></name> <name><surname>Petit</surname> <given-names>A</given-names></name> <article-title>Molecular biology and genetics of Alzheimer's disease</article-title> <source>C R Biol</source> <year>2005</year> <volume>328</volume> <fpage>119</fpage> <lpage>30</lpage></element-citation></ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<name><surname>Raha</surname><given-names>S</given-names></name> <name><surname>Robinson</surname> <given-names>BH</given-names></name> <article-title>Mitochondria, oxygen free radicals, disease and ageing</article-title> <source>Trends Biochem Sci</source> <year>2000</year> <volume>25</volume> <fpage>502</fpage> <lpage>08</lpage></element-citation></ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<name><surname>Uchida</surname><given-names>K</given-names></name> <name><surname>Okamoto</surname><given-names>N</given-names></name> <name><surname>Ohara</surname><given-names>K</given-names></name> <name><surname>Morita</surname> <given-names>Y</given-names></name> <article-title>Daily rhythm of serum melatonin in patients with dementia of degenerative type</article-title> <source>Brain Res</source> <year>1996</year> <volume>717</volume> <fpage>154</fpage> <lpage>59</lpage></element-citation></ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<name><surname>Wu</surname><given-names>YH</given-names></name> <name><surname>Mahittijs</surname><given-names>GP</given-names></name> <name><surname>Feenstra</surname><given-names>MG</given-names></name> <etal/> <article-title>Molecular changes underlying reduced pineal melatonin levels in Alzheimer's disease: alterations in preclinical and clinical stages</article-title> <source>J Clin Endocrinol Metab</source> <year>2003</year> <volume>88</volume> <fpage>5898</fpage> <lpage>5906</lpage></element-citation></ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<name><surname>Cardinali</surname><given-names>DP</given-names></name> <name><surname>Brusco</surname><given-names>LI</given-names></name> <name><surname>Liberczuk</surname><given-names>C</given-names></name> <name><surname>Furio</surname> <given-names>AM</given-names></name> <article-title>The use of melatonin in Alzheimer's disease</article-title> <source>Neuroendocrinol Lett</source> <year>2002</year> <volume>23</volume> <fpage>20</fpage><lpage>23</lpage></element-citation></ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<name><surname>Magri</surname><given-names>F</given-names></name> <name><surname>Locatelli</surname><given-names>M</given-names></name> <name><surname>Balza</surname><given-names>G</given-names></name><etal/> <article-title>Changes in endocrine circadian rhythms as marker of physiological and pathological brain aging</article-title> <source>Chronobiol Int</source> <year>1997</year> <volume>14</volume> <fpage>385</fpage> <lpage>96</lpage></element-citation></ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<name><surname>Skene</surname><given-names>DJ</given-names></name> <name><surname>Swaab</surname> <given-names>DF</given-names></name> <article-title>Melatonin rhytmicity: effects of age and Alzheimer's disease</article-title> <source>Exp Gerontol</source> <year>2003</year> <volume>38</volume> <fpage>199</fpage> <lpage>206</lpage></element-citation></ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<name><surname>Beai</surname> <given-names>MF</given-names></name> <article-title>Mitochondria, free radicals and neurodegenration</article-title> <source>Curr Opin Neurol</source> <year>1996</year> <volume>6</volume> <fpage>661</fpage> <lpage>66</lpage></element-citation></ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<name><surname>Bordet</surname><given-names>R</given-names></name> <name><surname>Devos</surname><given-names>D</given-names></name> <name><surname>Brique</surname><given-names>S</given-names></name> <etal/> <article-title>Study of circadian melatonin secretion pattern at different stages of Parkinson's disease</article-title> <source>Clin Neuropharmacol</source> <year>003</year> <volume>26</volume> <fpage>65</fpage> <lpage>72</lpage></element-citation></ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<name><surname>Poeggeler</surname> <given-names>B</given-names></name> <article-title>Melatonin, ageing and age-related diseases: perspectives for prevention, intervention and therapy</article-title> <source>Endocrine</source> <year>2005</year> <volume>27</volume> <fpage>201</fpage> <lpage>12</lpage></element-citation></ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<name><surname>Reiter</surname><given-names>RJ</given-names></name> <name><surname>Tan</surname><given-names>DX</given-names></name> <name><surname>Mayo</surname><given-names>JC</given-names></name> <etal/> <article-title>Melatonin as an antioxidant: biochemical mechanism and pathophysiolgical implications in humans</article-title> <source>Acta Biochim Pol</source> <year>2003</year> <volume>50</volume> <fpage>1129</fpage> <lpage>46</lpage></element-citation></ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<name><surname>Hardeland</surname><given-names>R</given-names></name> <name><surname>Pandi-Perumal</surname><given-names>SR</given-names></name> <name><surname>Cardinali</surname><given-names>DP</given-names></name> <article-title>Molecules in focus-Melatonin</article-title> <source>Int J Biochem Ceil Biol</source> <year>2006</year> <volume>38</volume> <fpage>313</fpage> <lpage>16</lpage></element-citation></ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<name><surname>Srinivasan</surname> <given-names>V</given-names></name> <article-title>Psychoactive drugs, pineal gland and affective disorders</article-title> <source>Prog Neuropshycopharmacol Biol Psychiat</source> <year>1989</year> <volume>13</volume> <fpage>653</fpage> <lpage>64</lpage></element-citation></ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<name><surname>Fainstein</surname><given-names>I</given-names></name> <name><surname>Bonetto</surname><given-names>A</given-names></name> <name><surname>Brusco</surname><given-names>U</given-names></name> <name><surname>Cardinali</surname> <given-names>DP</given-names></name> <article-title>Effects of melatonin in elderly patients with sleep disturbance</article-title> <source>Curr Ther Res</source> <year>1997</year> <volume>58</volume> <fpage>990</fpage> <lpage>1000</lpage></element-citation></ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<name><surname>Sainz</surname><given-names>RM</given-names></name> <name><surname>Mayo</surname><given-names>JC</given-names></name> <name><surname>Rodriguez</surname><given-names>C</given-names></name> <etal/> <article-title>Melatonin and cell death: differential actions on apoptosis and cancer cells</article-title> <source>Cell Mol Life Sci</source> <year>2003</year> <volume>60</volume> <fpage>1407</fpage> <lpage>26</lpage></element-citation></ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<name><surname>Stephen</surname><given-names>D Skaper</given-names></name> <name><surname>Biancamaria</surname><given-names>A</given-names></name> <name><surname>Laura</surname><given-names>F</given-names></name> <name><surname>Davide</surname><given-names>F</given-names></name> <name><surname>Pietro</surname> <given-names>G</given-names></name> <article-title>Melatonin prevents the delayed death of hippocampal neurons by enhanced excitatory neurotransmission and the nitridergic pathway</article-title> <source>Faseb J</source> <year>1998</year> <volume>12</volume> <fpage>725</fpage> <lpage>31</lpage></element-citation></ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<name><surname>Gupta</surname><given-names>YK</given-names></name> <name><surname>Gupta</surname><given-names>M</given-names></name> <name><surname>Kohli</surname> <given-names>K</given-names></name> <article-title>Neuroprotective role of melatonin in oxidative stress vulnerable brain</article-title> <source>Indian J Physiol Pharmacol</source> <year>2003</year> <volume>47</volume> <fpage>373</fpage> <lpage>86</lpage></element-citation></ref>
</ref-list>
</back>
</article>
